# Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)

> **NCT00845845** · PHASE2 · TERMINATED · sponsor: **University of Illinois at Chicago** · enrollment: 12 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis (NASH)
- Hepatic Steatosis

## Interventions

- **DRUG:** Omega-3-acid ethyl esters (Lovaza)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00845845
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Terminated due to low enrollment.
- **Last updated:** 2013-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845845, "Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00845845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*